Back to top

NRXP: Analyst Jason Kolbert Maintains 'Buy' Rating at $31.00 | NRXP Stock News

NRXP: Analyst Jason Kolbert Maintains 'Buy' Rating at $31.00 | NRXP Stock News

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

NRx Pharmaceuticals, Inc. (NRXP)